Literature DB >> 1551405

A single mRNA encodes the alpha 150 and alpha 80/70 forms of the alpha subunit of VLA4.

M Rubio1, A Nueda, A Vara, A L Corbí Lopez.   

Abstract

VLA4 is a cell surface heterodimer (alpha 4 beta 1, CD49d/CD29) which belongs to the integrin family and is involved in cell-extracellular matrix interactions, as well as in intercellular adhesion. Unlike other integrin alpha subunits, the alpha subunit of VLA4 (alpha 4) can appear as a 150-kDa polypeptide (alpha 150), or cleaved into two non-covalently associated polypeptides (alpha 70-80). The relative proportion of each form is highly variable among different cells and is dependent on the state of cellular activation. The alpha 4 cleavage site has recently been shown to occur between residues Arg558-Ser559. We report the isolation of genomic clones encoding the alpha 4 subunit, the location of the cleavage site-encoding nucleotides to a specific exon and the determination of the exon-intron organization around the cleavage site. Comparison with the gpIIb (CD41) and the alpha x (p150,95 alpha, CD11c) genes revealed a similar genomic structure in this region, with exons of similar length separated by introns of identical phase. The structure of the alpha 4 mRNA in cells expressing the alternative forms of alpha 4 has been analyzed by means of reverse transcription-polymerase chain reaction. Our results indicate that the exon encoding the cleavage site is present in alpha 4 mRNA molecules from cells expressing either the alpha 150 or the alpha 70-80 form on the cell surface. Moreover, the structure of the alpha 4 mRNA around the cleavage site does not change during the switch towards the alpha 70-80 form that takes place upon lymphocyte activation. Therefore, both forms of alpha 4 arise from a common mRNA, the alpha 150 form contains the cleavage sequence and the alpha 70-80 form must be generated by a post-translational proteolytic event.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551405     DOI: 10.1002/eji.1830220434

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  2 in total

1.  Inhibition of VLA-4 and up-regulation of TIMP-1 expression in B16BL6 melanoma cells transfected with MHC class I genes.

Authors:  F Xu; T Carlos; M Li; O Sanchez-Sweatman; R Khokha; E Gorelik
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

2.  Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia.

Authors:  A Chorzalska; I Salloum; H Shafqat; S Khan; P Marjon; D Treaba; C Schorl; J Morgan; C R Bryke; V Falanga; T C Zhao; J Reagan; E Winer; A J Olszewski; A S Al-Homsi; N Kouttab; P M Dubielecka
Journal:  Leukemia       Date:  2014-04-04       Impact factor: 11.528

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.